115 related articles for article (PubMed ID: 1975804)
1. Antibody to HTLV-I in indigenous inhabitants of the Andes and Amazon regions in Colombia.
Zamora T; Zaninovic V; Kajiwara M; Komoda H; Hayami M; Tajima K
Jpn J Cancer Res; 1990 Aug; 81(8):715-9. PubMed ID: 1975804
[TBL] [Abstract][Full Text] [Related]
2. HTLV-I/II infection among immigrants to Spain.
Vallejo A; Gutiérrez M; Soriano V
Vox Sang; 1994; 67(1):79-80. PubMed ID: 7975460
[No Abstract] [Full Text] [Related]
3. Epidemiological features of HTLV-I carriers and incidence of ATL in an ATL-endemic island: a report of the community-based co-operative study in Tsushima, Japan.
Tajima K; Kamura S; Ito S; Ito M; Nagatomo M; Kinoshita K; Ikeda S
Int J Cancer; 1987 Dec; 40(6):741-6. PubMed ID: 2891624
[TBL] [Abstract][Full Text] [Related]
4. Human T-lymphotropic virus type I (HTLV-I) provirus-related DNA sequences in peripheral blood mononuclear cells of a patient, in the absence of a definite serological positivity.
Re MC; Furlini G; Ramazzotti E; D'Antuono A; Vignoli M; La Placa M; Monari P; Zauli G; La Placa M
New Microbiol; 1993 Oct; 16(4):373-9. PubMed ID: 7903409
[TBL] [Abstract][Full Text] [Related]
5. Human T cell leukemia virus (HTLV-I/II) serodiagnostic testing: disparate results among a cohort of intravenous drug users.
Aboulafia DM; Feigal E; Vranzian K; Bennett C; Blattner W; Moss A; Slamon D
AIDS Res Hum Retroviruses; 1993 Oct; 9(10):1043-50. PubMed ID: 7904169
[TBL] [Abstract][Full Text] [Related]
6. HTLV-I/II seropositivity among eligible blood donors from Minas Gerais State, Brasil.
Proietti FA; Lima-Martins MV; Passos VM; Brener S; Carneiro-Proietti AB
Vox Sang; 1994; 67(1):77. PubMed ID: 7975458
[No Abstract] [Full Text] [Related]
7. Seroepidemiological and molecular studies of human T cell lymphotropic virus type II, subtype b, in isolated groups of Mataco and Toba Indians of northern Argentina.
Biglione M; Vidan O; Mahieux R; de Colombo M; de los Angeles de Basualdo M; Bonnet M; Pankow G; De Efron MA; Zorrilla A; Tekaia F; Murphy E; de Thé G; Gessain A
AIDS Res Hum Retroviruses; 1999 Mar; 15(5):407-17. PubMed ID: 10195750
[TBL] [Abstract][Full Text] [Related]
8. A seroepidemiological study of HTLV-1 infection in Nepal.
Ishida T; Takayanagi K; Shotake T; Hirai K; Yuasa I
Scand J Infect Dis; 1992; 24(3):399-400. PubMed ID: 1354887
[TBL] [Abstract][Full Text] [Related]
9. [Determination of anti-HTLV-I/II antibodies: Experience in 28,897 blood donations in Buenos Aires].
Blejer JL; Saguier MC; Salamone HJ; Carreras LA
Sangre (Barc); 1995 Dec; 40(6):447-51. PubMed ID: 8850226
[TBL] [Abstract][Full Text] [Related]
10. Geographic independence of HTLV-I and HTLV-II foci in the Andes highland, the Atlantic coast, and the Orinoco of Colombia.
Zaninovic V; Sanzon F; Lopez F; Velandia G; Blank A; Blank M; Fujiyama C; Yashiki S; Matsumoto D; Katahira Y
AIDS Res Hum Retroviruses; 1994 Jan; 10(1):97-101. PubMed ID: 8179968
[TBL] [Abstract][Full Text] [Related]
11. Failure to detect serological evidence of HTLV-I/II infection among HIV patients in Cuba.
Palenzuela D; Rivero J; Nazabal M
Vox Sang; 1994; 67(1):78. PubMed ID: 7975459
[No Abstract] [Full Text] [Related]
12. Human T-cell lymphotropic virus antibody prevalence in HIV-1-infected individuals attending a sexual health clinic in South-East London.
Cooke FJ; Geretti AM; Zuckerman M
J Med Virol; 2005 Jun; 76(2):143-5. PubMed ID: 15834880
[TBL] [Abstract][Full Text] [Related]
13. Seroepidemiology of human T cell lymphotropic virus in the Republic of Panama.
Reeves WC; Levine PH; Cuevas M; Quiroz E; Maloney E; Saxinger WC
Am J Trop Med Hyg; 1990 Apr; 42(4):374-9. PubMed ID: 1970459
[TBL] [Abstract][Full Text] [Related]
14. [Detection of antibodies against T-cell lymphotropic virus HTLV-I/II in Cuban patients with chronic renal failure undergoing hemodialysis].
Rivero RA; Hernández P; Suárez O; Hidalgo-Gato R; Navea LM; Yamaguchi K; Ballester JM
Sangre (Barc); 1992 Jun; 37(3):205-6. PubMed ID: 1359655
[No Abstract] [Full Text] [Related]
15. Evaluation of the human T-cell leukemia virus type I seropositivity of blood donors by the particle agglutination inhibition test.
Kwon KW; Ikeda H; Yano M; Sekiguchi S
Jpn J Cancer Res; 1989 Sep; 80(9):833-9. PubMed ID: 2513300
[TBL] [Abstract][Full Text] [Related]
16. HTLV infection in ELISA-negative blood donors.
Zehender G; Girotto M; De Maddalena C; Francisco G; Moroni M; Galli M
AIDS Res Hum Retroviruses; 1996 May; 12(8):737-40. PubMed ID: 8744584
[TBL] [Abstract][Full Text] [Related]
17. [Prevalence and prognostic significance of anti-HTLV-I and anti-HIV-2 antibodies in patients with HIV infection in the Roman region].
Antinori A; Tamburrini E; Ventura G; Nervo P; Ortona L
Boll Ist Sieroter Milan; 1988; 67(5-6):345-50. PubMed ID: 2908738
[TBL] [Abstract][Full Text] [Related]
18. Characteristic distribution of HTLV type I and HTLV type II carriers among native ethnic groups in South America.
Fujiyoshi T; Li HC; Lou H; Yashiki S; Karino S; Zaninovic V; Oneegllo SG; Camacho M; Andrade R; Hurtado LV; Gomez LH; Damiani E; Cartier L; Dipierri JE; Hayami M; Sonoda S; Tajima K
AIDS Res Hum Retroviruses; 1999 Sep; 15(14):1235-9. PubMed ID: 10505671
[TBL] [Abstract][Full Text] [Related]
19. Serological, epidemiological, and molecular differences between human T-cell lymphotropic virus Type 1 (HTLV-1)-seropositive healthy carriers and persons with HTLV-I Gag indeterminate Western blot patterns from the Caribbean.
Rouet F; Meertens L; Courouble G; Herrmann-Storck C; Pabingui R; Chancerel B; Abid A; Strobel M; Mauclere P; Gessain A
J Clin Microbiol; 2001 Apr; 39(4):1247-53. PubMed ID: 11283036
[TBL] [Abstract][Full Text] [Related]
20. Absence of HTLV-I infection among seronegative subjects in an endemic area of Japan.
Kinoshita T; Imamura J; Nagai H; Ito M; Ito S; Ikeda S; Nagatomo M; Tajima K; Shimotohno K
Int J Cancer; 1993 Apr; 54(1):16-9. PubMed ID: 8097497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
